CAM
GMED icon

Cresset Asset Management’s Globus Medical GMED Stock Holding History

Cresset Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387K Buy
4,897
+535
+12% +$45.5K ﹤0.01% 1276
2026
Q1 		$376K Buy
4,362
+784
+22% +$70.4K ﹤0.01% 1187
2025
Q4 		$312K Buy
3,578
+14
+0.4% +$1.06K ﹤0.01% 1280
2025
Q3 		$204K Buy
+3,564
New +$205K ﹤0.01% 1418
2024
Q4 		– Sell
-5,801
Closed -$415K – 1941
2024
Q3 		$415K Sell
5,801
-524
-8% -$37K ﹤0.01% 1632
2024
Q2 		$433K Sell
6,325
-461
-7% -$27.5K ﹤0.01% 1513
2024
Q1 		$364K Sell
6,786
-144
-2% -$7.74K ﹤0.01% 1483
2023
Q4 		$369K Sell
6,930
-2,527
-27% -$123K ﹤0.01% 1388
2023
Q3 		$470K Buy
9,457
+1,868
+25% +$104K ﹤0.01% 1216
2023
Q2 		$452K Buy
+7,589
New +$432K ﹤0.01% 1333

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cresset Asset Management's GMED Position: Q2 2026 in Review

Cresset Asset Management increased its Globus Medical (GMED) stake by 12% in Q2 2026, buying an estimated $45.5K and bringing the position to 4,897 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #1276.

Cresset Asset Management first reported a position in GMED in Q2 2023 and has held it in 10 quarters since. The position peaked at $470K in Q3 2023. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Cresset Asset Management held 4,897 shares of Globus Medical worth $387K as of Q2 2026.
  • Cresset Asset Management bought 535 Globus Medical shares in Q2 2026, an estimated $45.5K.
  • Globus Medical made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1276 holding.
  • Cresset Asset Management first reported a position in Globus Medical in Q2 2023 and has held it in 10 quarters since.
  • Cresset Asset Management's Globus Medical position peaked at $470K in Q3 2023.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.